9 results found.

Neoplasms Clinical Trial using BI 853520

Boehringer Ingelheim - Recruiting 18 years or older.
- An Open Label Phase I Dose Finding Study of BI 853520 Administered Orally in a Continuous Dosing Schedule in Patients With Various Advanced or Metastatic Non-hematologic Malignancies.
BI 853520

Neoplasms, Hematologic Clinical Trial using 120 mg LY2784544

Eli Lilly and Company - Recruiting 18 years or older.
- A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms.
120 mg LY2784544

Hematologic Neoplasms, Neural Tube Defects, or Myeloproliferative Clinical Trial using therapeutic allogeneic lymphocytes; Sirolimus

National Institutes of Health Clinical Center (CC) - Recruiting 11 years to 90 years.
- Allogeneic HSCT Without Preparative Chemotherapy or With Low-Intensity Preparative Chemotherapy Using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome.
therapeutic allogeneic lymphocytes; Sirolimus

Myelodysplastic Syndrome (MDS), Hematologic Neoplasms, Hematologi Clinical Trial using Cord Blood Transplant

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications.
Cord Blood Transplant

Acute Myeloid Leukemia, Infantile Leukemia (Both AML and ALL), My Clinical Trial using Sorafenib; Cytarabine; Clofarabine

St. Jude Children's Research Hospital - Recruiting N/A to 31 years.
- A Pilot Pharmacokinetic, Pharmacodynamic and Feasibility Study of Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies.
Sorafenib; Cytarabine; Clofarabine

Cancer of the Liver, Liver Cancer, Hepatoma, Liver Neoplasms, or Clinical Trial using Salmonella typhimurium

Masonic Cancer Center, University of Minnesota - Recruiting 18 years or older.
- A Phase 1 Study of an IL-2 Expressing, Attenuated Salmonella Typhimurium in Patients With Unresectable Hepatic Spread From Any Non-Hematologic Primary.
Salmonella typhimurium

Neoplasms, or Hematologic Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members.

Hematologic Neoplasms Clinical Trial

Inje University - Recruiting N/A or older.
- Biomarker Research for Personalized Medicine in Blood Cancer Patient.

Hematologic Neoplasms Clinical Trial using Cyclophosphamide; Hematopoietic Stem Cell Transplantation,

European Institute of Oncology - Recruiting 18 years to 70 years.
- Nonmyeloablative Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies With Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression With Cyclophosphamide Administered Before and After Transplantation..
Cyclophosphamide; Hematopoietic Stem Cell Transplantation,